Young consumers are driving demand for faster, smarter and more seamless payments that prioritize convenience, security and ...

PEDS, the first and largest Phase 3 study specifically designed to evaluate pediatric patients with severe alopecia areata ...

Amazon will sponsor signature community events in Chicago, Houston and Dallas, bringing together safety education, technology and local action to help end impaired driving. FOR IMMEDIATE RELEASE ...

Amazon's ‘Prime Big Deal Days' sale goes live on October 6th and 7th. We've broken down whether you need an active Amazon ...

Lilly's Olumiant receives US FDA approval for paediatric patients 12 years of age and older with severe alopecia areata: Indianapolis Monday, September 28, 2026, 16:00 Hrs [IST] E ...

AR’s TREAT Asia program works with partners in Indonesia and Malaysia to bolster the HIV prevention response in the era of ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration ( FDA) approved Olumiant (baricitinib), a once-daily pill, for the treatment of pediatric patients ...

Food and product recalls have affected millions of items in 2026. Learn how clinicians can help patients assess their ...

"The North Face = outdoor or for young people"—there are still a surprisingly large number of people who stop at this ...

The results showed that adults over 65 are the ones who take the most supplements: of the respondents who are older than this ...

PEDS, the first and largest Phase 3 study specifically designed to evaluate pediatric patients with severe alopecia areata (AA) Treatment with Olumiant resulted in substantial scalp hair regrowth, as ...

Baricitinib (Olumiant) is FDA-approved for pediatric patients 12 years of age and older with severe alopecia areata, in ...